Abstract
Lung cancer ranks as the most prevalent malignant neoplasm worldwide, contributing significantly to cancer-related mortality. Stemness is a well-recognized factor underlying radiotherapy resistance, recurrence and metastasis in non-small-cell lung cancer (NSCLC) patients. Our prior investigations have established the role of IQ motif containing GTPase-activating protein 3 (IQGAP3) in mediating radiotherapy resistance in lung cancer, but its impact on lung cancer stemness remains unexplored. Our bioinformatics analysis results revealed a significant correlation between IQGAP3 and lung cancer stemness. Moreover, we found that IQGAP3 depletion in lung cancer cells resulted in reduced migration, invasion and sphere-forming capabilities. Through RNA sequencing, we identified GLI1 as a pivotal downstream effector of IQGAP3. The knockdown of IQGAP3 led to the downregulation of GLI1 mRNA and protein levels, which impeded the activation of the Hedgehog-GLI1 signaling pathway. Further, our results also indicated that GLI1 is the primary effector mediating IQGAP3's biological functions in lung cancer. These findings elucidate the role of IQGAP3 in promoting lung cancer stemness and metastasis through the Hedgehog pathway, facilitated by GLI1, highlighting the potential of IQGAP3 as a promising therapeutic target for lung cancer treatment.
Introduction
Despite advancements in personalized medicine, the five-year survival rate for non-small-cell lung cancer (NSCLC) remains low, primarily due to metastasis and recurrence. These processes are driven by cancer stem cells (CSCs), a resilient subpopulation capable of self-renewal and resistance to conventional therapies. While IQ motif containing GTPase-activating protein 3 (IQGAP3) has been linked to radiotherapy resistance, its role in maintaining the "stemness" of lung cancer cells—the qualities that allow them to persist and spread—has only recently been uncovered.
Methodology
Researchers employed a multi-disciplinary approach to investigate the IQGAP3-Hedgehog axis:
- Bioinformatics & Clinical Correlation: Analysis of TCGA data was performed to calculate an mRNA stemness index (mRNAsi) and evaluate the correlation between IQGAP3 expression and patient survival.
- Functional Assays: siRNA was used to knock down IQGAP3 in A549 and H1299 cell lines. The impact on cellular behavior was measured through wound-healing (migration), Transwell (invasion), and sphere-formation (stemness) assays.
- Transcriptomic Profiling: RNA sequencing (RNA-seq) identified GLI1 as a critical downstream target of IQGAP3.
- Mechanistic Validation: Co-Immunoprecipitation (Co-IP) confirmed a physical interaction between IQGAP3 and GLI1. Rescue experiments using the Hedgehog pathway agonist SAG were conducted to determine if pathway re-activation could override the effects of IQGAP3 depletion.
Clinical Significance and Prognostic Value
Bioinformatic analysis and tissue validation demonstrate that IQGAP3 is significantly overexpressed in lung cancer tissues compared to normal lung tissue. High levels of IQGAP3 are associated with more advanced pathologic stages (T and N stages) and serve as an independent risk factor for poor overall survival (OS), progression-free survival (PFS), and disease-specific survival (DSS).
The IQGAP3-GLI1-Hedgehog Axis
Functional studies revealed that silencing IQGAP3 dramatically reduces the number of tumor spheres and slows cell migration and invasion. Mechanistically, IQGAP3 physically interacts with and up-regulates GLI1, a key transcription factor in the Hedgehog signaling pathway. This interaction is essential for maintaining the expression of core stemness markers such as NANOG and Oct4. Furthermore, IQGAP3 knockdown was shown to reverse the Epithelial-Mesenchymal Transition (EMT), increasing E-cadherin expression while decreasing N-cadherin and Vimentin. The partial restoration of invasive capabilities by the Hedgehog agonist SAG confirms that IQGAP3’s biological functions are largely mediated through the Hedgehog-GLI1 signaling pathway.
Conclusion
This study identifies IQGAP3 as a master regulator of lung cancer stemness and metastasis. By activating the Hedgehog-GLI1 axis, IQGAP3 promotes an aggressive tumor phenotype and therapeutic resistance. These findings highlight IQGAP3 as a high-value therapeutic target, offering a potential strategy to "de-stem" lung cancer cells and improve patient outcomes.
Limitations and Future Work: While the current evidence is robust, further validation in animal xenograft models is necessary. Additionally, future research should aim to elucidate the specific biochemical domains responsible for the physical interaction between IQGAP3 and GLI1.
Summary updated